And from the multivariate Cox regression analysis, there were four CXC subfamily ligands (CXCL9, CXCL10, CXCL11, and CXCL13) significantly associated with CRC patients’ DFS (all p<0.05). This evidence concerns the gene CXCL13 and colorectal carcinoma.